- Home
- BCYC vs ABL Comparison
BCYC vs ABL Comparison
Compare BCYC & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- ABL
- Stock Information
- Founded
- BCYC 2009
- ABL 2004
- Country
- BCYC United Kingdom
- ABL United States
- Employees
- BCYC N/A
- ABL N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- ABL Investment Managers
- Sector
- BCYC Health Care
- ABL Finance
- Exchange
- BCYC Nasdaq
- ABL Nasdaq
- Market Cap
- BCYC 581.7M
- ABL 687.7M
- IPO Year
- BCYC 2019
- ABL N/A
- Fundamental
- Price
- BCYC $8.34
- ABL $8.83
- Analyst Decision
- BCYC Buy
- ABL Strong Buy
- Analyst Count
- BCYC 10
- ABL 4
- Target Price
- BCYC $25.00
- ABL $13.63
- AVG Volume (30 Days)
- BCYC 401.9K
- ABL 436.1K
- Earning Date
- BCYC 05-01-2025
- ABL 05-08-2025
- Dividend Yield
- BCYC N/A
- ABL N/A
- EPS Growth
- BCYC N/A
- ABL N/A
- EPS
- BCYC N/A
- ABL N/A
- Revenue
- BCYC $25,722,000.00
- ABL $134,575,948.00
- Revenue This Year
- BCYC N/A
- ABL $64.80
- Revenue Next Year
- BCYC $0.27
- ABL $24.39
- P/E Ratio
- BCYC N/A
- ABL N/A
- Revenue Growth
- BCYC N/A
- ABL 73.39
- 52 Week Low
- BCYC $6.10
- ABL $6.34
- 52 Week High
- BCYC $28.67
- ABL $12.40
- Technical
- Relative Strength Index (RSI)
- BCYC 49.88
- ABL 70.94
- Support Level
- BCYC $7.95
- ABL $8.12
- Resistance Level
- BCYC $9.55
- ABL $8.47
- Average True Range (ATR)
- BCYC 0.72
- ABL 0.30
- MACD
- BCYC 0.05
- ABL 0.03
- Stochastic Oscillator
- BCYC 43.98
- ABL 51.55
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.